Trial Profile
Liposoms (drug delivery systems) in kinetically guided therapy of ovarian platinum-resistant carcinoma with doxorubicin using plasmafiltration.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 20 Dec 2016 New trial record